ABSTRACT
Abstract Quinacrine, a fluorescent basic molecule, accumulates in secretory granules of pituitary cells, as was revealed by its colocalization with immunoreactive prolactin. Thus quinacrine fluorescence may be used to monitor secretory activity at the single cell level. Rat pituitary cells in primary culture were loaded with quinacrine and stimulated with physiological secretagogues, such as thyrotrophin-releasing hormone or bradykinin, which induced a multiphasic lowering of fluorescence, corresponding to the loss of quinacrine contained in exocytosed granules. Quinacrine was further used in combination with the fluorescent calcium probe fura-2, in order to monitor simultaneously exocytosis and variations in the cytosolic free calcium concentration, [Ca(2+)](i). With an appropriate selection of the excitation wavelengths, in dual excitation microfluorimetry experiments, it was possible to distinguish between fluorescence changes due to altered [Ca(2+)](i) versus quinacrine exocytosis. Transient elevations of [Ca(2+)](i) were provoked in individual pituitary cells by enhancing calcium influx through voltage gated channels. In part of the cells an initial increase in [Ca(2+)](i) coincided with stimulated quinacrine release. The approach was also applied to cells of the neuroblastoma line NCB20, where stimulation with bradykinin caused a transient rise in [Ca(2+)](i), concomitantly with enhanced exocytosis. No increase in exocytosis was ever detected without an elevation of [Ca(2+)](i), suggesting that in both cellular systems, an increase in [Ca(2+)](i), is absolutely necessary, but not sufficient to induce secretion.
ABSTRACT
alpha-MSH and other fragments of ACTH are potent stimulators of GH release in vivo. The action of such peptides and of extracts of the neurointermediary lobe (NIL) of rat pituitary, a source of endogenous MSH-related peptides, on GH release was investigated in vitro. Peptides with the core sequence of alpha-MSH stimulate GH secretion by primary cultures of rat anterior pituitary cells; however, both the absolute and the relative potencies of these peptides exclude the involvement of melanotropic receptors comparable in specificity to the extrapituitary receptors for these hormones. Extracts of the NIL of rat pituitary stimulate GH release in vitro and the bulk of the releasing activity can be attributed to one (or several) factors with an apparent mass of approx. 10 000 M.W. that can be partially purified by HPLC. The active principle appears to be distinct from both beta-LPH and the human pancreatic GHRF. Thus, while rat NIL contains GH-releasing activity that can be demonstrated in vitro, a direct link to the potent action of MSH-related peptides on GH release in vivo cannot be established, and the action of these peptides in vivo must therefore rely on mechanisms which are not expressed in the in vitro system.
